So I was off by 1%, still 12-14% of NSCLC is triple the currently assumed population. Best part, we will have Pfizer, Novartis, and Roche/Chugai handing out flyers to all MD's in no time.
Let's hope Foundation Medicine comes through for us with a best-in-class diagnostic for ALK detection.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.